Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit

被引:82
作者
Beaulieu, JM [1 ]
Jacomy, H [1 ]
Julien, JP [1 ]
机构
[1] McGill Univ, Montreal Gen Hosp, Res Inst, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada
关键词
neurofilament; peripherin; intermediate filament; transgenic mouse; ALS; amyotrophic lateral sclerosis; motor neuron disease; neurodegeneration;
D O I
10.1523/JNEUROSCI.20-14-05321.2000
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Protein aggregates containing intermediate filaments (IFs) are a hallmark of degenerating spinal motor neurons in amyotrophic lateral sclerosis (ALS). Recently, we reported that a deficiency in neurofilament light subunit (NF-L), a phenomenon associated with ALS, promoted the formation of IF inclusions with ensuing motor neuron death in transgenic mice overproducing peripherin, a type III IF protein detected in axonal inclusions of ALS patients. To further assess the role of NF-L in the formation of abnormal IF inclusions, we generated transgenic mice overexpressing human neurofilament heavy subunits (hNF-H) in a context of targeted disruption of the NF-L gene (hH; L-/- mice). The hH; L-/- mice exhibited motor dysfunction, and they developed nonfilamentous protein aggregates containing NF-H and peripherin proteins in the perikarya of spinal motor neurons. However, the perikaryal protein aggregates in the hH; L-/- mice did not provoke motor neuron death, unlike toxic IF inclusions induced by peripherin overexpression in NF-L null mice (Per; L-/- mice). Our results indicate that different types of IF protein aggregates with distinct properties may occur in a context of NF-L deficiency and that an axonal localization of such aggregates may be an important factor of toxicity.
引用
收藏
页码:5321 / 5328
页数:8
相关论文
共 40 条
  • [11] PROGRESSIVE NEURONOPATHY IN TRANSGENIC MICE EXPRESSING THE HUMAN NEUROFILAMENT HEAVY GENE - A MOUSE MODEL OF AMYOTROPHIC-LATERAL-SCLEROSIS
    COTE, F
    COLLARD, JF
    JULIEN, JP
    [J]. CELL, 1993, 73 (01) : 35 - 46
  • [12] CRAPPERMCLACHLA.DR, 1988, MOL BRAIN RES, V3, P255
  • [13] IMMUNOCYTOCHEMICAL VISUALIZATION OF THE GOLGI-APPARATUS IN SEVERAL SPECIES, INCLUDING HUMAN, AND TISSUES WITH AN ANTISERUM AGAINST MG-160, A SIALOGLYCOPROTEIN OF RAT GOLGI-APPARATUS
    CROUL, S
    MEZITIS, SGE
    STIEBER, A
    CHEN, YJ
    GONATAS, JO
    GOUD, B
    GONATAS, NK
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (07) : 957 - 963
  • [14] NEUROFILAMENT-DEFICIENT AXONS AND PERIKARYAL AGGREGATES IN VIABLE TRANSGENIC MICE EXPRESSING A NEUROFILAMENT-BETA-GALACTOSIDASE FUSION PROTEIN
    EYER, J
    PETERSON, A
    [J]. NEURON, 1994, 12 (02) : 389 - 405
  • [15] INTERMEDIATE FILAMENTS - STRUCTURE, DYNAMICS, FUNCTION, AND DISEASE
    FUCHS, E
    WEBER, K
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 : 345 - 382
  • [16] HOFFMAN PN, 1975, J CELL BIOL, V642, P316
  • [17] Houseweart MK, 1999, J NEUROSCI, V19, P6446
  • [18] Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits
    Jacomy, H
    Zhu, QZ
    Couillard-Després, S
    Beaulieu, JM
    Julien, JP
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) : 972 - 984
  • [19] JULIEN JP, 1983, J BIOL CHEM, V258, P4019
  • [20] EXPRESSION AND ASSEMBLY OF A HUMAN NEUROFILAMENT PROTEIN IN TRANSGENIC MICE PROVIDE A NOVEL NEURONAL MARKING SYSTEM
    JULIEN, JP
    TRETJAKOFF, I
    BEAUDET, L
    PETERSON, A
    [J]. GENES & DEVELOPMENT, 1987, 1 (10) : 1085 - 1095